Atlas Trials

Two Anti-CD20 Regimens for Fibrillary Glomerulonephritis

Clinical trial NCT06680349 · COMPLETED

Trial details

NCT number
NCT06680349
Sponsor
University of Turin, Italy
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Fibrillary Glomerulonephritis
Start date
2022-12-01
Primary completion
2024-01-02
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.